New Delhi: India is unlikely to budge from its opposition to the provisions on regulatory data protection and patent extension in free trade talks with the EU and the UK, it has told its negotiating partners, in a move aimed at protecting its generic drug industry and healthcare schemes. New Delhi’s stand has been “firmly communicated", said a person aware …
Pfizer Inc has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill. Pictured: People walk by the Pfizer world headquarters in New York, November 9 Generic drug companies will be allowed to produce the pill for use in 95 countries, making up about 53% of the world's population 'It's quite significant that …
